Gloria C Chi1, Annette L Fitzpatrick1,2,3, Monisha Sharma1, Nancy S Jenny4, Oscar L Lopez5, Steven T DeKosky6. 1. Department of Epidemiology, University of Washington School of Public Health, Seattle. 2. Department of Family Medicine, University of Washington School of Medicine, Seattle. 3. Department of Global Health, University of Washington School of Public Health, Seattle. 4. Department of Pathology and Laboratory Medicine, University of Vermont School of Medicine, Burlington. 5. Department of Neurology, University of Pittsburgh School of Medicine, Pennsylvania. 6. McKnight Brain Institute and Department of Neurology, University of Florida College of Medicine, Gainesville.
Abstract
BACKGROUND: Vascular risk factors, including inflammation, may contribute to dementia development. We investigated the associations between peripheral inflammatory biomarkers and cognitive decline in five domains (memory, construction, language, psychomotor speed, and executive function). METHODS: Community-dwelling older adults from the Ginkgo Evaluation of Memory Study (n = 1,159, aged 75 or older) free of dementia at baseline were included and followed for up to 7 years. Ten biomarkers were measured at baseline representing different sources of inflammation: vascular inflammation (pentraxin 3 and serum amyloid P), endothelial function (endothelin-1), metabolic function (adiponectin, resistin, and plasminogen activating inhibitor-1), oxidative stress (receptor for advanced glycation end products), and general inflammation (interleukin-6, interleukin-2, and interleukin-10). A combined z-score was created from these biomarkers to represent total inflammation across these sources. We utilized generalized estimating equations that included an interaction term between z-scores and time to assess effect of inflammation on cognitive decline, adjusting for demographics (such as age, race/ethnicity, and sex), cardiovascular risk factors, and apolipoprotein E ε4 carrier status. A Bonferroni-adjusted significance level of .01 was used. We explored associations between individual biomarkers and cognitive decline without adjustment for multiplicity. RESULTS: The combined inflammation z-score was significantly associated with memory and psychomotor speed (p < .01). Pentraxin 3, serum amyloid P, endothelin-1, and interleukin-2 were associated with change in at least one cognitive domain (p < .05). CONCLUSION: Our results suggest that total inflammation is associated with memory and psychomotor speed. In particular, systemic inflammation, vascular inflammation, and altered endothelial function may play roles in domain-specific cognitive decline of nondemented individuals.
BACKGROUND: Vascular risk factors, including inflammation, may contribute to dementia development. We investigated the associations between peripheral inflammatory biomarkers and cognitive decline in five domains (memory, construction, language, psychomotor speed, and executive function). METHODS: Community-dwelling older adults from the Ginkgo Evaluation of Memory Study (n = 1,159, aged 75 or older) free of dementia at baseline were included and followed for up to 7 years. Ten biomarkers were measured at baseline representing different sources of inflammation: vascular inflammation (pentraxin 3 and serum amyloid P), endothelial function (endothelin-1), metabolic function (adiponectin, resistin, and plasminogen activating inhibitor-1), oxidative stress (receptor for advanced glycation end products), and general inflammation (interleukin-6, interleukin-2, and interleukin-10). A combined z-score was created from these biomarkers to represent total inflammation across these sources. We utilized generalized estimating equations that included an interaction term between z-scores and time to assess effect of inflammation on cognitive decline, adjusting for demographics (such as age, race/ethnicity, and sex), cardiovascular risk factors, and apolipoprotein E ε4 carrier status. A Bonferroni-adjusted significance level of .01 was used. We explored associations between individual biomarkers and cognitive decline without adjustment for multiplicity. RESULTS: The combined inflammation z-score was significantly associated with memory and psychomotor speed (p < .01). Pentraxin 3, serum amyloid P, endothelin-1, and interleukin-2 were associated with change in at least one cognitive domain (p < .05). CONCLUSION: Our results suggest that total inflammation is associated with memory and psychomotor speed. In particular, systemic inflammation, vascular inflammation, and altered endothelial function may play roles in domain-specific cognitive decline of nondemented individuals.
Authors: Giuseppe Castellano; Angela Di Vittorio; Giuseppe Dalfino; Antonia Loverre; Daniela Marrone; Simona Simone; Francesco Paolo Schena; Giovanni Pertosa; Giuseppe Grandaliano Journal: Atherosclerosis Date: 2009-08-31 Impact factor: 5.162
Authors: Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg Journal: JAMA Date: 2008-11-19 Impact factor: 56.272
Authors: Lindsay M Miller; Nancy S Jenny; Andreea M Rawlings; Alice M Arnold; Annette L Fitzpatrick; Oscar L Lopez; Michelle C Odden Journal: J Gerontol A Biol Sci Med Sci Date: 2020-07-13 Impact factor: 6.053
Authors: Cutter A Lindbergh; Kaitlin B Casaletto; Adam M Staffaroni; Fanny Elahi; Samantha M Walters; Michelle You; John Neuhaus; Will Rivera Contreras; Paul Wang; Anna Karydas; Jesse Brown; Amy Wolf; Howie Rosen; Yann Cobigo; Joel H Kramer Journal: J Gerontol A Biol Sci Med Sci Date: 2020-07-13 Impact factor: 6.053
Authors: Premranjan Kumar; Chun Liu; Jean W Hsu; Shaji Chacko; Charles Minard; Farook Jahoor; Rajagopal V Sekhar Journal: Clin Transl Med Date: 2021-03
Authors: Andy Judge; Cesar Garriga; Nigel K Arden; Simon Lovestone; Dani Prieto-Alhambra; Cyrus Cooper; Christopher J Edwards Journal: Alzheimers Dement (N Y) Date: 2017-11-09